Insight Molecular Diagnostics Inc. held its 2025 Annual Meeting of Shareholders on June 27, 2025, virtually via live webcast. The proposals presented included the election of four director nominees: Joshua Riggs, Andrew Arno, Andrew J. Last, and Louis E. Silverman, all of whom were elected. The appointment of CBIZ CPAs P.C. as the independent registered public accounting firm for the year ending December 31, 2025, was ratified. An amendment to the Amended and Restated 2018 Equity Incentive Plan to increase the total number of shares authorized for issuance by 1,500,000, to a total of 3,800,000 shares, was also approved.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.